Celcuity (CELC) Total Current Liabilities (2016 - 2026)
Celcuity's (CELC) quarterly Total Current Liabilities came in at $44.2 million in Q4 2025, up 39.18% YoY from $31.7 million in Q4 2024, and up 13.82% on a QoQ basis from $38.8 million in Q3 2025.
Celcuity (CELC) Total Current Liabilities (2016 - 2026) Analysis & Trends
Celcuity (CELC) has 10 years of Total Current Liabilities data on file, last reported at $44.2 million in Q4 2025.
- Quarterly Total Current Liabilities rose 39.18% year-over-year to $44.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $44.2 million (up 39.18% YoY) and the FY2025 annual result came in at $44.2 million, up 39.18% from the prior year.
- Total Current Liabilities advanced to $44.2 million in Q4 2025, from $38.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $44.2 million in Q4 2025 to a low of $1.2 million in Q1 2021.
- A 5-year average of $16.0 million and a median of $9.9 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Current Liabilities jumped 35.33% — and 2022, when it soared 203.35%.
- Tracing CELC's Total Current Liabilities over 5 years: stood at $2.5 million in 2021, then jumped by 174.64% to $6.9 million in 2022, then surged by 106.19% to $14.2 million in 2023, then soared by 123.58% to $31.7 million in 2024, then soared by 39.18% to $44.2 million in 2025.
- The last three Total Current Liabilities figures came in at $44.2 million (Q4 2025), $38.8 million (Q3 2025), and $39.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | 86.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.87 Mn |
| Dec 31, 2025 | 44.15 Mn |
| Sep 30, 2025 | 38.79 Mn |
| Jun 30, 2025 | 39.94 Mn |
| Mar 31, 2025 | 32.92 Mn |
| Dec 31, 2024 | 31.72 Mn |
| Sep 30, 2024 | 26.31 Mn |
| Jun 30, 2024 | 19.53 Mn |
| Mar 31, 2024 | 16.70 Mn |
| Dec 31, 2023 | 14.19 Mn |
| Sep 30, 2023 | 12.71 Mn |
| Jun 30, 2023 | 7.08 Mn |
| Mar 31, 2023 | 5.81 Mn |
| Dec 31, 2022 | 6.88 Mn |
| Sep 30, 2022 | 6.65 Mn |
| Jun 30, 2022 | 4.15 Mn |
| Mar 31, 2022 | 3.55 Mn |
| Dec 31, 2021 | 2.51 Mn |
| Sep 30, 2021 | 2.82 Mn |
| Jun 30, 2021 | 1.54 Mn |